浅全基因组测序全景拷贝数分析提升多发性骨髓瘤风险分层
研究开发LeukoPrint浅全基因组测序法,对3家医院423例多发性骨髓瘤患者进行全基因组拷贝数分析,并与核型和FISH比较。LeukoPrint异常检出率75.2%显著高于核型11.2%,与FISH关键预后CNAs一致率94.0%,整合Mayo风险模型使11.5%标危患者重分类为高危。
要点
- LeukoPrint异常检出率75.2%,显著高于核型11.2%。
- 与FISH关键预后CNAs一致率94.0%,可替代核型联合FISH。
- 整合Mayo模型使11.5%标危患者重分类为高危。
核心结论
- LeukoPrint显著优于传统核型且与FISH关键CNA标记高度一致,可作为MM细胞遗传学分析和预后风险分层的替代方案。
研究设计与样本
- 开发LeukoPrint浅全基因组测序法,分析3家医院423例MM患者的CNA谱,并与核型和FISH比较诊断性能及预后评估临床效用。
主要发现
- LeukoPrint异常检出率75.2%,核型为11.2%。
- 在核型阴性病例中,LeukoPrint检出73.3%存在CNAs。
- 与FISH对关键预后CNAs(amp(1q)、del(1p)、del(13q)、del(17p))的一致率为94.0%。
- 整合LeukoPrint与FISH结果进入Mayo风险模型,将11.5%标危患者重分类为高危。
- LeukoPrint全景分析揭示超二倍体与非超二倍体MM具有不同CNA模式。
关键数值与推荐
- 推荐以LeukoPrint联合FISH替代核型用于常规诊断。
临床怎么用
- 采用LeukoPrint联合FISH进行MM常规细胞遗传学诊断,替代核型分析。
- 将LeukoPrint与FISH结果整合至Mayo风险模型,识别可从强化治疗获益的高危患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Comprehensive detection of copy number aberrations (CNAs) is critical for precise prognostic risk stratification in multiple myeloma (MM), yet conventional cytogenetic methods remain limited. We developed LeukoPrint, a shallow whole-genome sequencing (sWGS) assay for genome-wide CNA profiling. Using this platform, we analyzed CNA profiles of 423 patients with MM across 3 hospitals and compared LeukoPrint with karyotyping and fluorescence in situ hybridization (FISH) to evaluate its diagnostic performance and clinical utility in prognostic assessment. Compared with karyotyping, LeukoPrint demonstrated a significantly higher abnormality detection rate (75.2% vs 11.2%) and identified CNAs in 73.3% of karyotyping-negative cases. Concordance with FISH for key prognostic CNAs (amp(1q), del(1p), del(13q), del(17p)) was 94.0%. Based on these findings, we propose replacing karyotyping with LeukoPrint combined with FISH for routine diagnostics. Integrating LeukoPrint with FISH results into the Mayo Stratification for Myeloma and Risk-Adapted Therapy risk model reclassified 11.5% of standard-risk patients as high-risk, identifying candidates for intensified therapy. Furthermore, LeukoPrint genome-wide profiling revealed distinct CNA patterns between hyperdiploid and nonhyperdiploid MM, informing biological heterogeneity. LeukoPrint significantly outperforms conventional karyotyping and closely matches FISH for critical CNA markers, offering an alternative for cytogenetic profiling and prognostic risk stratification in MM.
引用
- Fang B, Zhu Z, Chang Y, et al. Genome-wide copy number profiling enhances risk stratification in multiple myeloma by shallow whole-genome sequencing. Blood Adv. 2026. PMID: 41385406. doi:10.1182/bloodadvances.2025018133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。